Skip to main content

Advertisement

Log in

Inflammasomes: current understanding and open questions

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

The innate immune system relies on its capability to detect invading microbes, tissue damage, or stress via evolutionarily conserved receptors. The nucleotide-binding domain leucine-rich repeat (NLR)-containing family of pattern recognition receptors includes several proteins that drive inflammation in response to a wide variety of molecular patterns. In particular, the NLRs that participate in the formation of a molecular scaffold termed the “inflammasome” have been intensively studied in past years. Inflammasome activation by multiple types of tissue damage or by pathogen-associated signatures results in the autocatalytic cleavage of caspase-1 and ultimately leads to the processing and thus secretion of pro-inflammatory cytokines, most importantly interleukin (IL)-1β and IL-18. Here, we review the current knowledge of mechanisms leading to the activation of inflammasomes. In particular, we focus on the controversial molecular mechanisms that regulate NLRP3 signaling and highlight recent advancements in DNA sensing by the inflammasome receptor AIM2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bella J, Hindle KL, McEwan PA, Lovell SC (2008) The leucine-rich repeat structure. Cell Mol Life Sci 65:2307–2333

    CAS  PubMed  Google Scholar 

  2. Duncan JA, Bergstralh DT, Wang Y, Willingham SB, Ye Z, Zimmermann AG, Ting JP (2007) Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA 104:8041–8046

    CAS  PubMed  Google Scholar 

  3. Ting JP et al (2008) The NLR gene family: a standard nomenclature. Immunity 28:285–287

    CAS  PubMed  Google Scholar 

  4. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426

    CAS  PubMed  Google Scholar 

  5. Faustin B et al (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 25:713–724

    CAS  PubMed  Google Scholar 

  6. Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38:240–244

    CAS  PubMed  Google Scholar 

  7. Franchi L et al (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:576–582

    CAS  PubMed  Google Scholar 

  8. Bauernfeind FG et al (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787–791

    CAS  PubMed  Google Scholar 

  9. Allen IC et al (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30:556–565

    CAS  PubMed  Google Scholar 

  10. Roberts TL et al (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057–1060

    CAS  PubMed  Google Scholar 

  11. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509–513

    CAS  PubMed  Google Scholar 

  12. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514–518

    CAS  PubMed  Google Scholar 

  13. Burckstummer T et al (2009) An orthogonal proteomic–genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10:266–272

    PubMed  Google Scholar 

  14. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550

    CAS  PubMed  Google Scholar 

  15. Wilson KP et al (1994) Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370:270–275

    CAS  PubMed  Google Scholar 

  16. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7:99–109

    CAS  PubMed  Google Scholar 

  17. Andrei C, Margiocco P, Poggi A, Lotti LV, Torrisi MR, Rubartelli A (2004) Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: implications for inflammatory processes. Proc Natl Acad Sci USA 101:9745–9750

    CAS  PubMed  Google Scholar 

  18. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15:825–835

    CAS  PubMed  Google Scholar 

  19. Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179:1913–1925

    CAS  PubMed  Google Scholar 

  20. Puren AJ, Fantuzzi G, Dinarello CA (1999) Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA 96:2256–2261

    CAS  PubMed  Google Scholar 

  21. Okamura H et al (1995) A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 63:3966–3972

    CAS  PubMed  Google Scholar 

  22. Schmitz J et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490

    CAS  PubMed  Google Scholar 

  23. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104:282–287

    CAS  PubMed  Google Scholar 

  24. Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 106:9021–9026

    CAS  PubMed  Google Scholar 

  25. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G (2009) Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 284:19420–19426

    CAS  PubMed  Google Scholar 

  26. Luthi AU et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84–98

    CAS  PubMed  Google Scholar 

  27. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265

    CAS  PubMed  Google Scholar 

  28. Bouchier-Hayes L, Martin SJ (2004) CARDINAL roles in apoptosis and NFkappaB activation. Vitam Horm 67:133–147

    CAS  PubMed  Google Scholar 

  29. Fernandes-Alnemri T et al (2007) The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14:1590–1604

    CAS  PubMed  Google Scholar 

  30. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319–325

    CAS  PubMed  Google Scholar 

  31. Faustin B, Chen Y, Zhai D, Le Negrate G, Lartigue L, Satterthwait A, Reed JC (2009) Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization. Proc Natl Acad Sci USA 106:3935–3940

    CAS  PubMed  Google Scholar 

  32. Bruey JM et al (2007) Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129:45–56

    CAS  PubMed  Google Scholar 

  33. Hsu LC et al (2008) A NOD2–NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA 105:7803–7808

    CAS  PubMed  Google Scholar 

  34. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869–8872

    CAS  PubMed  Google Scholar 

  35. Ferwerda G et al (2008) Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta. Eur J Immunol 38:184–191

    CAS  PubMed  Google Scholar 

  36. Banks DJ, Ward SC, Bradley KA (2006) New insights into the functions of anthrax toxin. Expert Rev Mol Med 8:1–18

    PubMed  Google Scholar 

  37. Nour AM, Yeung YG, Santambrogio L, Boyden ED, Stanley ER, Brojatsch J (2009) Anthrax lethal toxin triggers the formation of a membrane-associated inflammasome complex in murine macrophages. Infect Immun 77:1262–1271

    CAS  PubMed  Google Scholar 

  38. Squires RC, Muehlbauer SM, Brojatsch J (2007) Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing. J Biol Chem 282:34260–34267

    CAS  PubMed  Google Scholar 

  39. Fink SL, Bergsbaken T, Cookson BT (2008) Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci USA 105:4312–4317

    CAS  PubMed  Google Scholar 

  40. Wickliffe KE, Leppla SH, Moayeri M (2008) Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome. Cell Microbiol 10:332–343

    CAS  PubMed  Google Scholar 

  41. Jin Y, Birlea SA, Fain PR, Spritz RA (2007) Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 127:2558–2562

    CAS  PubMed  Google Scholar 

  42. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA (2007) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356:1216–1225

    CAS  PubMed  Google Scholar 

  43. Tu CX, Gu JS, Lin XR (2003) Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci 31:73–78

    CAS  PubMed  Google Scholar 

  44. Wagner RN, Proell M, Kufer TA, Schwarzenbacher R (2009) Evaluation of Nod-like receptor (NLR) effector domain interactions. PLoS One 4:e4931

    PubMed  Google Scholar 

  45. Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 276:28309–28313

    CAS  PubMed  Google Scholar 

  46. Mariathasan S et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213–218

    CAS  PubMed  Google Scholar 

  47. Zamboni DS et al (2006) The Birc 1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 7:318–325

    CAS  PubMed  Google Scholar 

  48. Suzuki T et al (2007) Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 3:e111

    PubMed  Google Scholar 

  49. Miao EA, Ernst RK, Dors M, Mao DP, Aderem A (2008) Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci USA 105:2562–2567

    CAS  PubMed  Google Scholar 

  50. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7:569–575

    CAS  PubMed  Google Scholar 

  51. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE (2006) Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2:e18

    PubMed  Google Scholar 

  52. Warren SE, Mao DP, Rodriguez AE, Miao EA, Aderem A (2008) Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 180:7558–7564

    CAS  PubMed  Google Scholar 

  53. Lightfield KL et al (2008) Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol 9:1171–1178

    CAS  PubMed  Google Scholar 

  54. Lamkanfi M et al (2007) The Nod-like receptor family member Naip5/Birc 1e restricts Legionella pneumophila growth independently of caspase-1 activation. J Immunol 178:8022–8027

    CAS  PubMed  Google Scholar 

  55. Sutterwala FS, Mijares LA, Li L, Ogura Y, Kazmierczak BI, Flavell RA (2007) Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 204:3235–3245

    CAS  PubMed  Google Scholar 

  56. Franchi L, Stoolman J, Kanneganti TD, Verma A, Ramphal R, Nunez G (2007) Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur J Immunol 37:3030–3039

    CAS  PubMed  Google Scholar 

  57. Miao EA and Warren SE (2010) Innate immune detection of bacterial virulence factors via the NLRC4 inflammasome. J Clin Immunol 30:502–506

    Google Scholar 

  58. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301–305

    CAS  PubMed  Google Scholar 

  59. Manji GA et al (2002) PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 277:11570–11575

    CAS  PubMed  Google Scholar 

  60. Kanneganti TD et al (2006) Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 281:36560–36568

    CAS  PubMed  Google Scholar 

  61. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206:79–87

    CAS  PubMed  Google Scholar 

  62. Thomas PG et al (2009) The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30:566–575

    CAS  PubMed  Google Scholar 

  63. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, Tschopp J (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103–107

    CAS  PubMed  Google Scholar 

  64. Mariathasan S et al (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228–232

    CAS  PubMed  Google Scholar 

  65. Meixenberger K et al (2010) Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol 184:922–930

    CAS  PubMed  Google Scholar 

  66. Duncan JA et al (2009) Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 182:6460–6469

    CAS  PubMed  Google Scholar 

  67. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS (2009) Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 183:3578–3581

    CAS  PubMed  Google Scholar 

  68. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA (2009) An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5:487–497

    CAS  PubMed  Google Scholar 

  69. Gross O et al (2009) Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433–436

    CAS  PubMed  Google Scholar 

  70. Ichinohe T, Pang IK, Iwasaki A (2010) Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol 11:404–410

    CAS  PubMed  Google Scholar 

  71. Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071–5082

    CAS  PubMed  Google Scholar 

  72. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14:1583–1589

    CAS  PubMed  Google Scholar 

  73. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241

    CAS  PubMed  Google Scholar 

  74. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL (2006) MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest 116:2262–2271

    CAS  PubMed  Google Scholar 

  75. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847–856

    CAS  PubMed  Google Scholar 

  76. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677

    CAS  PubMed  Google Scholar 

  77. Cassel SL et al (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 105:9035–9040

    CAS  PubMed  Google Scholar 

  78. Eisenbarth SC, Colegio OR, O′Connor W, Sutterwala FS, Flavell RA (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122–1126

    CAS  PubMed  Google Scholar 

  79. Kool M et al (2008) Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 181:3755–3759

    CAS  PubMed  Google Scholar 

  80. Dostert C et al (2009) Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4:e6510

    PubMed  Google Scholar 

  81. Reimer T et al (2010) Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol 40(3):764–769

    Google Scholar 

  82. Shio MT et al (2009) Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 5:e1000559

    PubMed  Google Scholar 

  83. Griffith JW, Sun T, McIntosh MT, Bucala R (2009) Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol 183:5208–5220

    CAS  PubMed  Google Scholar 

  84. Halle A et al (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857–865

    CAS  PubMed  Google Scholar 

  85. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611–7615

    CAS  PubMed  Google Scholar 

  86. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of toll-like receptor signaling. Immunity 26:433–443

    CAS  PubMed  Google Scholar 

  87. Kanneganti TD et al (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440:233–236

    CAS  PubMed  Google Scholar 

  88. Franchi L, Eigenbrod T, Nunez G (2009) Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183:792–796

    CAS  PubMed  Google Scholar 

  89. Netea MG et al (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113:2324–2335

    CAS  PubMed  Google Scholar 

  90. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 105:8067–8072

    CAS  PubMed  Google Scholar 

  91. Perregaux D, Gabel CA (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269:15195–15203

    CAS  PubMed  Google Scholar 

  92. Arlehamn CS, Petrilli V, Gross O, Tschopp J, Evans TJ (2010) The role of potassium in inflammasome activation by bacteria. J Biol Chem 285:10508–10518

    CAS  PubMed  Google Scholar 

  93. Poeck H et al (2010) Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 11:63–69

    CAS  PubMed  Google Scholar 

  94. Fubini B, Hubbard A (2003) Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 34:1507–1516

    CAS  PubMed  Google Scholar 

  95. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282:2871–2879

    CAS  PubMed  Google Scholar 

  96. Rada B, Leto TL (2008) Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 15:164–187

    CAS  PubMed  Google Scholar 

  97. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140

    CAS  PubMed  Google Scholar 

  98. Pollock JD et al (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9:202–209

    CAS  PubMed  Google Scholar 

  99. Duewell P et al (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357–1361

    CAS  PubMed  Google Scholar 

  100. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27:621–668

    CAS  PubMed  Google Scholar 

  101. Feldmann J et al (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198–203

    CAS  PubMed  Google Scholar 

  102. Neven B et al (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103:2809–2815

    CAS  PubMed  Google Scholar 

  103. Gattorno M et al (2007) Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 56:3138–3148

    CAS  PubMed  Google Scholar 

  104. Yu JW et al (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 13:236–249

    CAS  PubMed  Google Scholar 

  105. Anderson JP, Mueller JL, Misaghi A, Anderson S, Sivagnanam M, Kolodner RD, Hoffman HM (2008) Initial description of the human NLRP3 promoter. Genes Immun 9:721–726

    CAS  PubMed  Google Scholar 

  106. Pontillo A, Brandao LA, Guimaraes RL, Segat L, Athanasakis E and Crovella S (2010) A 3′ UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 54:236–240

    Google Scholar 

  107. Goldbach-Mansky R et al (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355:581–592

    CAS  PubMed  Google Scholar 

  108. Yamamoto M et al (2004) ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9:1055–1067

    CAS  PubMed  Google Scholar 

  109. Li P et al (1995) Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401–411

    CAS  PubMed  Google Scholar 

  110. Sutterwala FS et al (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317–327

    CAS  PubMed  Google Scholar 

  111. De Gregorio E, Tritto E, Rappuoli R (2008) Alum adjuvanticity: unraveling a century old mystery. Eur J Immunol 38:2068–2071

    PubMed  Google Scholar 

  112. Morefield GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, Hem SL (2005) Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23:1588–1595

    CAS  PubMed  Google Scholar 

  113. Jordan MB, Mills DM, Kappler J, Marrack P, Cambier JC (2004) Promotion of B cell immune responses via an alum-induced myeloid cell population. Science 304:1808–1810

    CAS  PubMed  Google Scholar 

  114. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, Nemazee D (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314:1936–1938

    CAS  PubMed  Google Scholar 

  115. Nemazee D, Gavin A, Hoebe K, Beutler B (2006) Immunology: toll-like receptors and antibody responses. Nature 441:E4; discussion E4

  116. Li H, Willingham SB, Ting JP, Re F (2008) Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol 181:17–21

    CAS  PubMed  Google Scholar 

  117. McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P (2009) Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 183:4403–4414

    CAS  PubMed  Google Scholar 

  118. Franchi L, Nunez G (2008) The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol 38:2085–2089

    CAS  PubMed  Google Scholar 

  119. Ghiringhelli F et al (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15:1170–1178

    CAS  PubMed  Google Scholar 

  120. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J (2009) T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 460:269–273

    CAS  PubMed  Google Scholar 

  121. Hemmi H et al (2000) A toll-like receptor recognizes bacterial DNA. Nature 408:740–745

    CAS  PubMed  Google Scholar 

  122. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V (2009) RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10:1065–1072

    CAS  PubMed  Google Scholar 

  123. Takaoka A et al (2007) DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505

    CAS  PubMed  Google Scholar 

  124. Ishii KJ et al (2008) TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725–729

    CAS  PubMed  Google Scholar 

  125. Hornung V, Latz E (2010) Intracellular DNA recognition. Nat Rev Immunol 10:123–130

    CAS  PubMed  Google Scholar 

  126. Landolfo S, Gariglio M, Gribaudo G, Lembo D (1998) The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie 80:721–728

    CAS  PubMed  Google Scholar 

  127. Ludlow LE, Johnstone RW, Clarke CJ (2005) The HIN-200 family: more than interferon-inducible genes? Exp Cell Res 308:1–17

    CAS  PubMed  Google Scholar 

  128. Choubey D, Panchanathan R (2008) Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett 119:32–41

    CAS  PubMed  Google Scholar 

  129. Baechler EC et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100:2610–2615

    CAS  PubMed  Google Scholar 

  130. Fernandes-Alnemri T et al (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11:385–393

    CAS  PubMed  Google Scholar 

  131. Rathinam VA et al (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11:395–402

    CAS  PubMed  Google Scholar 

  132. Kim S, Bauernfeind F, Ablasser A, Hartmann G, Fitzgerald KA, Latz E, Hornung V (2010) Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol 40:1545–1551

    CAS  PubMed  Google Scholar 

  133. Koul D, Obeyesekere NU, Gutterman JU, Mills GB, Choubey D (1998) p202 self-associates through a sequence conserved among the members of the 200-family proteins. FEBS Lett 438:21–24

    CAS  PubMed  Google Scholar 

  134. Wang L et al (2002) PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 277:29874–29880

    CAS  PubMed  Google Scholar 

  135. Grenier JM et al (2002) Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett 530:73–78

    CAS  PubMed  Google Scholar 

  136. Harder J, Franchi L, Munoz-Planillo R, Park JH, Reimer T, Nunez G (2009) Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 183:5823–5829

    CAS  PubMed  Google Scholar 

  137. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126:1135–1145

    CAS  PubMed  Google Scholar 

  138. Munoz-Planillo R, Franchi L, Miller LS, Nunez G (2009) A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 183:3942–3948

    CAS  PubMed  Google Scholar 

  139. Sharp FA et al (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA 106:870–875

    CAS  PubMed  Google Scholar 

  140. Yamasaki K et al (2009) NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 284:12762–12771

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the German Research Foundation (SFB704 and SFB670) and the European Research Council (ERC‐2009‐StG 243046) to Veit Hornung.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Veit Hornung.

Additional information

F. Bauernfeind and A. Ablasser have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauernfeind, F., Ablasser, A., Bartok, E. et al. Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 68, 765–783 (2011). https://doi.org/10.1007/s00018-010-0567-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-010-0567-4

Keywords

Navigation